Skip to main content

Table 1 Baseline characteristics of the patients

From: The impact of ABCB1, CYP3A4/5 and ABCG2 gene polymorphisms on rivaroxaban trough concentrations and bleeding events in patients with non-valvular atrial fibrillation

Variables

Characteristics of patients (95)

Age (years)

65.8 ± 12.5

Female, n (%)

39 (41.0)

Body weight (kg)

67.8 ± 12.2

CrCl (mL/min)

77.3 ± 23.4

Dose, n (%)

 10 mg qd

21 (22.1)

 15 mg qd

71 (74.7)

 20 mg qd

3 (3.2)

  1. CrCl creatinine clearance, qd once daily